Related Experiment Video

Updated: Aug 14, 2026

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

Status of endothelial dependent vasodilation in patients with hyperuricemia

Masahiko Kato1, Ichiro Hisatome, Yoko Tomikura

  • 1Department of Cardiovascular Medicine, Graduate School of Medical Science, Tottori University, Yonago, Japan. mkato@grape.med.tottori-u.ac.jp

The American Journal of Cardiology
|November 29, 2005
PubMed

Insights

Elevated serum uric acid, a condition known as hyperuricemia, is linked to impaired endothelial function. This suggests that high uric acid levels may be a novel risk factor for cardiovascular disease.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Nephrology

Background:

  • Hyperuricemia is associated with increased cardiovascular disease (CVD) risk and mortality.
  • The biological mechanisms connecting elevated serum uric acid to CVD remain unclear.
  • Endothelial dysfunction is an early indicator of cardiovascular pathology.

Purpose of the Study:

  • To investigate the association between elevated serum uric acid and endothelial function in patients with hyperuricemia but no overt CVD.
  • To test the hypothesis that hyperuricemia impairs endothelial function.

Main Methods:

  • A case-control study involving 17 male patients with hyperuricemia and 9 healthy male control subjects.
  • Endothelial function was assessed using ultrasound to measure flow-mediated dilation (FMD).
  • Nitrate-induced dilation was also measured to assess endothelial-independent vasodilation.

Main Results:

  • Flow-mediated dilation was significantly lower in hyperuricemic patients (4.0±0.7%) compared to controls (6.4±0.8%), P=0.044.
  • Flow-mediated dilation showed an inverse correlation with serum uric acid levels (r=-0.4, P=0.05).
  • No significant difference was observed in nitrate-induced dilation between the groups, P=0.82.

Conclusions:

  • Hyperuricemic patients exhibit impaired endothelial-dependent vasodilation even without diagnosed cardiovascular disease.
  • Elevated serum uric acid itself may represent a novel risk factor for endothelial dysfunction.
  • These findings highlight the importance of addressing hyperuricemia in cardiovascular risk management.

More Related Videos

Assessing Endothelial Vasodilator Function with the Endo-PAT 200007:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Related Concept Videos

Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...